HLA haplotype diversity, islet autoantibody status and discriminative ability of type 1 diabetes genetic risk score in Indians
Diabetic Medicine · 2025
DOI: 10.1111/dme.70041 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetic Medicine, 2025. Verfasst von Alagu Sankareswaran und 8 weiteren Autor:innen. Beteiligte Einrichtung: Genomic Research on Complex Diseases Group (GRC-Group), CSIR-Centre for Cellular and Molecular Biology (CSIR-CCMB), Hyderabad, India. Hauptthemen laut MEDLINE: Autoantibodies, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, HLA Antigens. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: Council of Scientific and Industrial Research, India, Diabetes UK, UK, Diabetes UK.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Aims
We have reported that a 9SNPs type 1 diabetes (T1D) Genetic Risk Score (GRS) developed from European data had a lower power in Indians to distinguish T1D from type 2 diabetes (T2D). We explore the performance of an improved (67SNPs) T1DGRS and also the potential reasons for lower discriminative ability to classify types of diabetes in Indians.
Methods
We studied the discriminative ability of a 67SNPs European T1DGRS in 611 clinically diagnosed T1D and 1153 T2D patients, and 321 non‐diabetic controls, using receiver operating characteristic (ROC) area under the curve (AUC). We also compared the frequency and effect sizes of HLA risk haplotypes between Indians and Europeans.
Results
The T1DGRS was discriminative of T1D from T2D and controls. However, the ability is lower in Indians than Europeans (AUC, Europeans 0.92, Indians all T1D 0.83, AA‐positive 0.86). The T1DGRS was higher in AA‐positive than in AA‐negative persons [13.01 (12.79–13.23) vs. 12.09 (11.64–12.56)], p < 0.0001. The association of common HLA‐DQA1 ~ HLA‐DQB1 haplotypes was broadly similar; however, important differences were noted in the frequency, direction and magnitude of effect for some haplotypes between Indians and Europeans.
Conclusions
We confirm broad applicability of European 67SNPs T1DGRS to Indian T1D persons. However, differences in HLA allele frequencies, magnitude and directional differences reduced the predictive value. Our results stress the need to generate ancestry‐specific GRS, which we plan to do in the near future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Genomic Research on Complex Diseases Group (GRC-Group), CSIR-Centre for Cellular and Molecular Biology (CSIR-CCMB), Hyderabad, India.
- Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, India.
- Diabetes Unit, King Edward Memorial Hospital and Research Centre, Pune, India.
- University of Exeter College of Medicine and Health, Exeter, UK.
- Royal Devon University Healthcare NHS Foundation Trust, Exeter, UK.
ORCID-Profile: Alagu Sankareswaran, Richard A Oram, Chittaranjan S Yajnik
Förderung
- Council of Scientific and Industrial Research, India
- Diabetes UK, UK
- Diabetes UK
Zitieren
APA
Sankareswaran, A., Kunte, P., Fraser, D. P., Shaik, M., Lavanuru, D., Weedon, M. N., Oram, R. A., Yajnik, C. S., & Chandak, G. R. (2025). HLA haplotype diversity, islet autoantibody status and discriminative ability of type 1 diabetes genetic risk score in Indians. Diabetic Medicine. https://doi.org/10.1111/dme.70041
Vancouver
Sankareswaran A, Kunte P, Fraser DP, Shaik M, Lavanuru D, Weedon MN, et al. HLA haplotype diversity, islet autoantibody status and discriminative ability of type 1 diabetes genetic risk score in Indians. Diabetic Medicine. 2025. doi:10.1111/dme.70041
BibTeX
@article{Sankareswaran2025,
author = {Sankareswaran, Alagu and Kunte, Pooja and Fraser, Diane P and Shaik, Mobeen and Lavanuru, Dimple and Weedon, Michael N and Oram, Richard A and Yajnik, Chittaranjan S and Chandak, Giriraj R},
title = {HLA haplotype diversity, islet autoantibody status and discriminative ability of type 1 diabetes genetic risk score in Indians},
journal = {Diabetic Medicine},
year = {2025},
doi = {10.1111/dme.70041}
}
EUVIMED